Drug Trial Radar · NCT06668181
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Mar 11, 2025
Primary completion
Apr 12, 2028
Study completion Jul 31, 2030
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Oct 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess plasma bimekizumab concentrations following subcutaneous (sc) bimekizumab administration.
Conditions
- Enthesitis-related Arthritis
- Juvenile Psoriatic Arthritis
Interventions
BimekizumabDrug
Bimekizumab will be administered at pre-specified timepoints.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma bimekizumab concentrations over the Initial Treatment PeriodTime frame: Up to Week 16
Locations
23 sites in 6 countries. Site status is shown where the registry gives one.
Ja0005 50646
Calgary, Canada · Recruiting
Ja0005 50644
Montreal, Canada · Recruiting
Ja0005 50645
Saskatoon, Canada · Recruiting
Ja0005 40777
Indre-et-Loire, France · Recruiting
Ja0005 40510
Le Kremlin-Bicêtre, France · Recruiting
Ja0005 40778
Paris, France · Recruiting
Ja0005 40776
Poitiers, France · Recruiting
Ja0005 40369
Berlin, Germany · Recruiting
Ja0005 40356
Dresden, Germany · Recruiting
Ja0005 40072
Freiburg im Breisgau, Germany · Recruiting
Ja0005 40852
Hamburg, Germany · Recruiting
Ja0005 40787
Sankt Augustin, Germany · Recruiting
Ja0005 40779
Sendenhorst, Germany · Recruiting
Ja0005 40427
Tübingen, Germany · Recruiting
Ja0005 40720
Krakow, Poland · Withdrawn
Ja0005 40780
Sosnowiec, Poland · Recruiting
Ja0005 40781
Esplugues de Llobregat, Spain · Recruiting
Ja0005 40100
Madrid, Spain · Recruiting
Ja0005 40782
Valencia, Spain · Recruiting
Ja0005 40786
Bristol, United Kingdom · Recruiting
Ja0005 40783
Manchester, United Kingdom · Recruiting
Ja0005 40785
Nottingham, United Kingdom · Recruiting
Ja0005 40784
Stoke-on-Trent, United Kingdom · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.